BDNF is the potential serum biomarker of ALS with the C9orf72 mutation, while the C9orf72 repeat expansion elevates the risk of cognitive impairment in ALS and ALS‐FTD [22, 23]. The gene discussed is BDNF; the disease is Cognitive impairment.